http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-782448-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a5173a7d063a9f70ca7b5e86fc23863
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-16
filingDate 1955-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1957-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-782448-A
titleOfInvention N-aralkyl-n-(acyloxyalkyl)-halogenated-alkanoamides
abstract The invention comprises compounds of the formula <FORM:0782448/IV (a)/1> where Ar is a phenyl, naphthyl, biphenylyl, furyl, pyridyl or thienyl radical (which may have from one to three halo, lower alkoxy, methylenedioxy, ethylenedioxy, lower alkyl, lower alkylmercapto, lower alkylsulphonyl, nitro- or di-(lower alkyl)amino substituents, X is an alkylene radical having one to four carbon atoms, Y is an alkylene radical having two to six carbon atoms and having its two free valence bonds on different carbon atoms, Ac1 is a carboxylic acyl group having from one to eight carbon atoms and Ac is a lower halogenated-alkanoyl radical having one to four carbon atoms. Such compounds are obtained by reacting a compound having the formula <FORM:0782448/IV (a)/2> with an acylating agent having the formula Ac1-halogen or (Ac1)2O or, in the case where Ac1 is formyl, with formic acid. When Ac and Ac1 are alike, the products can be obtained without isolation of the intermediate N-aralkyl - N - (hydroxyalkyl) - halogenated alkanoamide by reacting an aralkylaminoalkanol (Ar-X-NH-Y-OH) with at least two molar equivalents of a halogenated alkanoyl halide. Radicals listed for Ac1 are formyl, haloformyl, alkanoyl, mono-, di- and trihaloalkanoyl, carboxyalkanoyl, di-(lower alkyl)aminoalkanoyl, benzoyl, alkoxybenzoyl, mono-, di- and trihalobenzoyl, including acetyl, butanoyl, 3-methylbutanoyl, hexanoyl, chloracetyl, bromoacetyl, 3 - iodopropanoyl, 2 fluorobutanoyl, dichloracetyl, 2,2 - bromopropanoyl, 2 - chloro - 3 - bromobutanoyl, tribromoacetyl, 2,2,3 - trichloropropanoyl, 2,3,4 - trichlorobutanoyl, 2,2 - dibromo - 6 - chlorohexanoyl, carboxyethanoyl, 2- or 3-carboxypropanoyl, 6 - carboxyhexanoyl, diethylaminoacetyl, 2-dimethylaminopropanoyl and 4-di-n-propylaminobutanoyl. Radicals listed for Ac are chloroformyl, chloroacetyl, iodoacetyl, fluoroacetyl, dichloroacetyl, dibromoacetyl, trichloroacetyl, 2-chloropropanoyl, 3-bromopropanoyl, 2,2 - diiodopropanoyl, 2 - bromo - 3 - chloropropanoyl, 2,2 - dichloropropanoyl, 2,2 - difluoropropanoyl, 2,2,3 - trichloropropanoyl, 2-chlorobutanoyl, 3 - bromobutanoyl, 2,2 - dichlorobutanoyl, 3,4 - dibromobutanoyl and 2,2,3- and 2,3,4-trichlorobutanoyl. The intermediate N-aralkyl-N-(hydroxy-alkyl)-halogenated alkanoamides are obtained by reacting the appropriate halogenated - alkanoylating agent with a compound of the formula Ar-X-NH-Y-OH. Such aralkylaminoalkanols are obtained by (a) reaction of an aralkyl halide Ar-X-halogen with an alkanolamine H2N-Y-OH; (b) for compounds where X is CH2, reaction of an aldehyde Ar-CHO with an alkanolamine H2N-Y-OH and catalytic hydrogenation of the resulting anil Ar-CH = N-Y-OH; (c) reaction of an aralkylamine Ar-X-NH2 with a haloalkanol, halogen-Y-OH. In Example (1A) 2-(4-isopropylbenzylamino)ethanol is prepared by reacting 4-isopropylbenzaldehyde and ethanolamine and hydrogenating the product. By the alternative method 2-(2,4-dichlorobenzylamino)ethanol is prepared by reacting 2,4-dichlorobenzyl chloride with ethanolamine; (1B) N - (3,4 - dichlorobenzyl) - N - (2 - hydroxyethyl)dichloracetamide is prepared by reacting N - (3,4 - dichlorobenzylamino)ethanol with dichloroacetyl chloride; (1C) N-(2,4-dichlorobenzyl) - N - (2 - chloracetoxyethyl)dichloracetamide is prepared by reacting N-(2,4-dichlorobenzyl) - N - (2 - hydroxyethyl)dichloracetamide with chloracetyl chloride; (2) N - (4 - isopropylbenzyl) - N - (2 - n - butanoyloxyethyl)dichloracetamide is prepared by reacting butanoic anhydride with N-(4-isopropylbenzyl) - N - (2 - hydroxyethyl)dichloracetamide; (3) N-(2,4-dichlorobenzyl)-N-[2 (3-carboxypropanoyl)ethyl] dichloracetamide is prepared by reacting N-(2,4-dichlorobenzyl)-N - (2 - hydroxyethyl)dichloracetamide with succinic anhydride; (4) N-(2,4-dichlorobenzyl)-N - [2 - (2,4 - dichlorobenzoxy)ethyl] dichloracetamide is obtained by reacting N-(2,4-dichlorobenzyl) - N - (2 - hydroxyethyl) dichloroacetamide with 2,4-dichlorobenzoyl chloride; (5) N - benzyl - N - (2 - formyloxyethyl) dichloracetamide is prepared by reacting N-benzyl - N - (2 - hydroxyethyl) dichloroacetamide with formic acid; (6) N-(2,4-dichlorobenzyl) - N - (2 - trichloroacetoxyethyl) - trichloroacetamide is prepared by reacting 2-(2,4 - dichlorobenzylamino)ethanol with trichloroacetyl chloride; (7) N-(2,4-dichlorobenzyl) - N - (2 - diethylamino - acetoxyethyl)dichloracetamide is prepared by reacting N-(2,4 - dichlorobenzyl) - N - (2 - chloroacetoxyethyl)dichloracetamide with diethylamine; (8A) 2 - (2,4 - dichlorobenzylamino)ethanol and chloracetyl chloride are reacted to give N-(2,4 - dichlorobenzyl) - N - (2 - hydroxyethyl)chloracetamide which (8B) is reacted with dichloroacetyl chloride to give N-(2,4-dichlorobenzyl) - N - (2 - dichloroacetoxyethyl) - chloracetamide; (9A) N-(2,4-dichlorobenzyl)-N-(2-hydroxyethyl)dichloroacetamide is treated in dioxane with anhydrous hydrogen chloride to give N - (2 - dichloroacetoxyethyl) - 2,4 - dichlorobenzylamine and this is reacted (9B) with trichloroacetyl chloride to give N-(2,4-dichlorobenzyl) - N - (2 - dichloroacetoxyethyl)-trichloracetamide. A large number of additional compounds (final products and intermediates) is described or listed. These illustrate various further combinations of the possible radicals which Ar, X, Y, Ac and Ac1 may represent. Specifications 747,592 and 767,246 are referred to.
priorityDate 1954-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432042725
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71432026
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432119744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432370650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154309526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428411213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419576604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154368952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431984960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420456400
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432475864
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431936946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520590
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431941521
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415891775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432023049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673794
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153803926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420165368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673797
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154173858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407631466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432113612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429283625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154118810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414862585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12694
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154100002
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID252529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154176646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID234280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154142276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154134218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457270017
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154097837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457673758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415905083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415734690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861630
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520945

Total number of triples: 78.